“borderline significant”

Chehrehgosha et al [ 20 ] reported a marked within-group CAP reduction with empagliflozin (317.37 ± 28.46 to 287.80 ± 31.14 dB/m), though the between-group difference versus placebo was borderline significant (−29.6 vs. −16.4 dB/m, P = 0.05).

A linear mixed effects model fitted to stimulus value ratings (i.e., how much participants wanted to eat the food items) found a main effect of group ( ß = 0.10, SE = 0.03, p = 0.003, 95% CI [0.03–0.16]), controlled for BMI, which had a borderline significant effect on stimulus value ratings ( ß = 0.01, SE = 0.006 p = 0.05, 95% CI [−0.0002 to 0.02]).

Borderline significant differences (P=0.05) were found when studies with a parallel design were compared with cross-over studies.

There was a borderline significant decrease in risk (0.01<P<0.05) with low dose unopposed equine oestrogen, low dose unopposed non-equine oestrogen, high dose unopposed non-equine oestrogen, and continuous high dose non-equine.

The standardized indirect effects for the MUSIC constructs on achievement were statistically significant for success ( p < 0.01) and interest ( p < 0.05), and borderline significant for caring ( p = 0.05), with the following values: 0.008 for empowerment ( p = 0.370), 0.010 for usefulness ( p = 0.184), 0.064 for success ( p = 0.006), 0.028 for interest ( p = 0.016), and − 0.016 for caring ( p = 0.050).

A borderline significant correlation was present when exciting with 440 nm (r = 0.57, p = 0.05) and 750 nm (r = 0.55, p = 0.06).

A borderline significant ( p = 0.05) finding was that Medicaid patients had poorer overall survival compared to uninsured patients (HR = 1.14, p = 0.05).

Moreover, a borderline significant increase in favorable neurological outcome was observed for Pol-AED care (Pol-AED: 77.8% vs. non-Pol-AED: 74.0%; p = 0.050) (see Table 2 ).

Linear modelling Among the selected predictors, the number of long term time series, population density, sustainable development index, and the number of tourists were found to be highly significant ( p < 0.05), whereas country growth and Trompenaar’s 7th dimension were borderline significant ( p = 0.05–0.06; Supplement 4).

Our analysis did not display anymore significant or borderline significant difference in study’s variables within tertiles of DQI-I, HEI-2015 and DPI ( P > 0.05).

2 , 3 ); differences were only significant for fibrous volume and borderline significant for necrotic-core volume ( P < 0.05 and P = 0.07, respectively).

Excluding the patients that had no measurable CTCs, there was a borderline significant difference between median CTC count in the patients that did and that did not have HER2-positive CTCs ( p = 0.05, Mann–Whitney U test).

Within each stimulus type, no significant difference in the mean amplitude of wave V across the test conditions was identified for ABR to click ( p >0.05) and the result for ABR to LS chirp was borderline significant ( p =0.05).

Moreover, in a prospective randomized, double-blind, placebo-controlled trial enrolling 106 patients with both NAFLD and T2DM who were assigned to receive empagliflozin 10 mg ( n = 35), pioglitazone 30 mg ( n = 34), or placebo ( n = 37) for 24 weeks, only a borderline significant decrease in CAP score was observed with empagliflozin compared with placebo (−29.6 dB/m (−39.5 to −19.6) vs. −16.4 dB/m (−25.0 to −7.8), respectively; p = 0.05) [ 39 ].

The Constant scores also showed more improvement in group S&P than group S at 2 years after surgery, but the mean difference in scores was borderline significant (13.4 vs 9.9, respectively; P = .050).

Age was also found to be a borderline significant factor (OR: 0.95, 95% CI: 0.89–1.01, P = 0.05), with younger patients tending to show greater improvement in fibrosis markers and grades.

However, there were some baseline differences (phase 0) between conditions as patients with COPD in GP practices showed a borderline significant decrease ( p = 0.050) in 2020 vs. 2019 compared to patients with asthma ( p = 0.507).

A borderline significant decrease was observed in all motility parameters VSL, VCL, VAP, DSL, DAP, ALH, BCF, LIN, STR, WOB in the EMR group at p = 0.05.

However, there was a borderline significant difference in gender distribution between the clusters ( χ 2 1 =3.84; P =.05).

This study found that patients with CeD, younger-onset diabetes, MS, asthma, and SLE were at higher risk of ALS, and the rate ratio for UC was borderline significant ( P = 0.05), and no significant difference was found for RA, psoriasis and CD.

In the multivariate analysis, there was a borderline significant risk reduction of 20% with increased activity (aHR moderate 0.80, 95% CI 0.63-1.00, p=0.05 and aHR high 0.80, 95% CI 0.64-1.01, p=0.06).

Acute lower respiratory symptoms were associated with lower CCL17 [estimate: 0.6 pg/ml, (95% CI: 0.5–0.8), p < 0.001] and a borderline significant lower level of CCL20 [estimate: 0.5 pg/ml (95% CI: 0.2–1.0), p = 0.05] ( Table 4 ).

However, the composite outcome of death or BPD was only borderline significant (40.0% vs. 46.3%, p = 0.05), and mortality alone was numerically higher in the budesonide group (16.9% vs. 13.6%, RR 1.24), although not statistically significant [ 40 ].

Sitting time shows a borderline significant positive association with anxiety in younger adults (adjusted β = 0.14, p = 0.050), suggesting that sedentary behavior may disproportionately affect the mental health of younger individuals, possibly due to higher stress levels or reduced opportunities for physical engagement during prolonged sitting periods.

One week after treatment ( Table 5 ), a borderline significant difference in coronary artery Z-scores was observed among the three groups (H = 6.00, P = 0.05).